293 related articles for article (PubMed ID: 27557832)
1. Exploring the role of physician communication about adjuvant endocrine therapy among breast cancer patients on active treatment: a qualitative analysis.
Farias AJ; Ornelas IJ; Hohl SD; Zeliadt SB; Hansen RN; Li CI; Thompson B
Support Care Cancer; 2017 Jan; 25(1):75-83. PubMed ID: 27557832
[TBL] [Abstract][Full Text] [Related]
2. Understanding adjuvant endocrine therapy persistence in breast Cancer survivors.
Lambert LK; Balneaves LG; Howard AF; Chia SK; Gotay CC
BMC Cancer; 2018 Jul; 18(1):732. PubMed ID: 29996816
[TBL] [Abstract][Full Text] [Related]
3. Provider perspectives on patient-provider communication for adjuvant endocrine therapy symptom management.
Turner K; Samuel CA; Donovan HA; Beckjord E; Cardy A; Dew MA; van Londen GJ
Support Care Cancer; 2017 Apr; 25(4):1055-1061. PubMed ID: 27864628
[TBL] [Abstract][Full Text] [Related]
4. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
[TBL] [Abstract][Full Text] [Related]
5. Exploring the role of social support and adjuvant endocrine therapy use among breast cancer survivors.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2020 Jan; 28(1):271-278. PubMed ID: 31037379
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
7. Religion and spirituality: their role in the psychosocial adjustment to breast cancer and subsequent symptom management of adjuvant endocrine therapy.
Toledo G; Ochoa CY; Farias AJ
Support Care Cancer; 2021 Jun; 29(6):3017-3024. PubMed ID: 33034750
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
[TBL] [Abstract][Full Text] [Related]
9. Provider perspectives on barriers and facilitators to adjuvant endocrine therapy-related symptom management.
Samuel CA; Turner K; Donovan HAS; Beckjord E; Cardy A; Dew MA; van Londen GJ
Support Care Cancer; 2017 Dec; 25(12):3723-3731. PubMed ID: 28681126
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of postmenopausal breast cancer survivors on adjuvant endocrine therapy-related symptoms.
van Londen GJ; Donovan HS; Beckjord EB; Cardy AL; Bovbjerg DH; Davidson NE; Morse JQ; Switzer GE; Verdonck-de Leeuw IM; Dew MA
Oncol Nurs Forum; 2014 Nov; 41(6):660-8. PubMed ID: 25355021
[TBL] [Abstract][Full Text] [Related]
11. The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.
Jacobs JM; Walsh EA; Park ER; Berger J; Peppercorn J; Partridge A; Horick N; Safren SA; Temel JS; Greer JA
Int J Behav Med; 2020 Dec; 27(6):687-697. PubMed ID: 32495240
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer patients' experiences of adherence and persistence to oral endocrine therapy: A qualitative evidence synthesis.
Clancy C; Lynch J; OConnor P; Dowling M
Eur J Oncol Nurs; 2020 Feb; 44():101706. PubMed ID: 32007696
[TBL] [Abstract][Full Text] [Related]
13. Both "Vitamin L for Life" and "One Milligram of Satan": A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer.
Toivonen KI; Oberoi D; King-Shier K; Piedalue KL; Rash JA; Carlson LE; Campbell TS
Curr Oncol; 2021 Jul; 28(4):2496-2515. PubMed ID: 34287250
[TBL] [Abstract][Full Text] [Related]
14. Understanding pain related to adjuvant endocrine therapy after breast cancer: A qualitative report.
Walsh EA; Chabria R; Vranceanu AM; Park ER; Post K; Peppercorn J; Temel JS; Greer JA; Jacobs JM
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13723. PubMed ID: 36196499
[TBL] [Abstract][Full Text] [Related]
15. Development of decision-support intervention for Black women with breast cancer.
Sheppard VB; Williams KP; Harrison TM; Jennings Y; Lucas W; Stephen J; Robinson D; Mandelblatt JS; Taylor KL
Psychooncology; 2010 Jan; 19(1):62-70. PubMed ID: 19267384
[TBL] [Abstract][Full Text] [Related]
16. Adherence to adjuvant endocrine therapy for breast cancer: a qualitative exploration of attribution of symptoms among post-menopausal women.
Lee AY; Lyons AT; Makris V; Kamaraju S; Stolley MR; Neuner JM; Flynn KE
Support Care Cancer; 2024 Apr; 32(4):265. PubMed ID: 38565669
[TBL] [Abstract][Full Text] [Related]
17. Optimization of an Information Leaflet to Influence Medication Beliefs in Women With Breast Cancer: A Randomized Factorial Experiment.
Green SMC; Hall LH; French DP; Rousseau N; Parbutt C; Walwyn R; Smith SG
Ann Behav Med; 2023 Oct; 57(11):988-1000. PubMed ID: 37494669
[TBL] [Abstract][Full Text] [Related]
18. Women with breast cancer's perceptions of nurse-led telephone-based motivational interviewing consultations to enhance adherence to adjuvant endocrine therapy: a qualitative study.
Gagné M; Lauzier S; Lemay M; Loiselle CG; Provencher L; Simard C; Guillaumie L
Support Care Cancer; 2022 Jun; 30(6):4759-4768. PubMed ID: 35133477
[TBL] [Abstract][Full Text] [Related]
19. The role of patient-provider communication for black women making decisions about breast cancer treatment.
Sheppard VB; Adams IF; Lamdan R; Taylor KL
Psychooncology; 2011 Dec; 20(12):1309-16. PubMed ID: 20941804
[TBL] [Abstract][Full Text] [Related]
20. Women's experiences with antiestrogen therapy to treat breast cancer.
Flanagan J; Winters LN; Habin K; Cashavelly B
Oncol Nurs Forum; 2012 Jan; 39(1):70-7. PubMed ID: 22201657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
